Eli Lilly’s Got A Sparkling New AI Biopharma Deal, And European Inflation Fears Are Rising

from The Finimize Daily Brief · host Finimize

The US maker of Zepbound just signed a $2.75 billion deal with Hong Kong-based Insilico Medicine for an AI-developed drug – while eurozone consumers and businesses say they expect prices to rise… and that suggests they will.Today’s stories:Eli Lilly’s Got A Sparkling New AI Biopharma DealInflation Fears Are Brewing Across EuropeTry Finimize Pro

Episode metadata supplied by the publisher feed · Published Mar 31, 2026

Embed this episode

Attribution link and audio player

Ready to play

Eli Lilly’s Got A Sparkling New AI Biopharma Deal, And European Inflation Fears Are Rising

0:00 5:42

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Finimize Daily Brief?

This episode is 5 minutes long.

When was this The Finimize Daily Brief episode published?

This episode was published on March 31, 2026.

Can I download this The Finimize Daily Brief episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!